Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» psoriatic arthritis
psoriatic arthritis
Skyrizi notches top pharma, Rx brand spot for Q3 2024
Medical Marketing and Media
Mon, 10/7/24 - 09:52 pm
AbbVie
Skyrizi
Crohn's Disease
psoriatic arthritis
UCB rapidly bolsters blockbuster potential for Bimzelx with 3 new FDA approvals
Fierce Pharma
Mon, 09/23/24 - 10:19 pm
UCB Pharma
Bimzelx
FDA
psoriatic arthritis
radiographic axial spondyloarthritis
ankylosing spondylitis
Alumis readies IPO to fund rival drug to Bristol Myers’ Sotyktu
BioPharma Dive
Mon, 06/10/24 - 11:17 am
Alumis
IPOs
funding
Bristol Myers Squibb
Sotyktu
psoriatic arthritis
Novartis Wins FDA Approval for Intravenous Cosentyx Formulation
BioSpace
Mon, 10/9/23 - 10:14 am
Novartis
Cosentyx
FDA
ankylosing spondylitis
psoriatic arthritis
non-radiographic axial spondyloarthritis
Plaque psoriasis and psoriatic arthritis: trials to watch in 2022
Clinical Trials Arena
Tue, 08/9/22 - 06:32 am
clinical trials
psoriasis
psoriatic arthritis
Lipidor
AKP-02
Amgen
ABP-654
Hengyi
HPP-737
Galapagos
Jyseleca
J&J nabs label expansion for Stelara in pediatric psoriatic arthritis
Endpoints
Tue, 08/2/22 - 12:03 am
JNJ
Stelara
pediatric
psoriatic arthritis
Psoriasis and psoriatic arthritis drugs crisscross categories, but derm and rheum docs split on preferences
Endpoints
Mon, 05/9/22 - 11:35 pm
psoriasis
psoriatic arthritis
dermatologists
rheumatologists
AbbVie Snags FDA Approval for Another Indication. Will It Become Another Blockbuster?
Motley Fool
Fri, 02/18/22 - 10:30 am
AbbVie
Skyrizi
FDA
psoriatic arthritis
AbbVie's (ABBV) Skyrizi Gets FDA Nod for Psoriatic Arthritis
Yahoo/Zacks.com
Mon, 01/24/22 - 11:30 pm
AbbVie
Skyrizi
FDA
psoriatic arthritis
Could This FDA Approval Create a Blockbuster Drug for AbbVie?
Motley Fool
Sun, 01/2/22 - 11:36 pm
AbbVie
Rinvoq
FDA
psoriatic arthritis
AbbVie (ABBV) Announces FDA Will Not Meet PDUFA Action Dates for RINVOQ sNDAs
Street Insider
Fri, 06/25/21 - 11:12 am
AbbVie
FDA
Rinvoq
psoriatic arthritis
J&J touts Tremfya win in Humira-resistant psoriatic arthritis patients amid showdown with AbbVie's Skyrizi
Fierce Pharma
Thu, 06/3/21 - 10:51 pm
JNJ
Tremfya
psoriatic arthritis
AbbVie
Skyrizi
AbbVie presents applications to FDA and EMA for approval of SKYRIZI in psoriatic arthritis
Pharmaceutical Business Review
Thu, 04/8/21 - 10:22 am
AbbVie
Skyrizi
FDA
EMA
psoriatic arthritis
Janssen's Psoriatic Arthritis Drug Proves Long-Term Efficacy in Two-Year Trial
BioSpace
Tue, 03/16/21 - 10:40 pm
JNJ
Janssen
clinical trials
Tremfya
psoriatic arthritis
AbbVie eyes Humira matching move into psoriatic arthritis for immunology follow-up Skyrizi
Endpoints
Tue, 01/5/21 - 11:03 pm
AbbVie
Humira
psoriatic arthritis
Skyrizi
Janssen’s Tremfya gets FDA approval for active psoriatic arthritis
Pharmaceutical Business Review
Wed, 07/15/20 - 10:20 am
Janssen
JNJ
FDA
Tremfya
psoriatic arthritis
Gilead builds case for filgotinib in active psoriatic arthritis
Fierce Biotech
Mon, 06/8/20 - 10:38 am
Gilead Sciences
Galapagos
filgotinib
clinical trials
psoriatic arthritis
Johnson & Johnson's Tremfya backs psoriatic arthritis play with newest data
Fierce Pharma
Tue, 11/12/19 - 10:03 am
JNJ
Tremfya
psoriatic arthritis
psoriasis
clinical trials
Eli Lilly's Taltz extends its head-to-head Humira beat with 52-week psoriatic arthritis data
Fierce Pharma
Tue, 11/12/19 - 09:51 am
Eli Lilly
Taltz
psoriatic arthritis
AbbVie
Humira
Novartis’ Cosentyx Narrowly Misses Beating Out AbbVie’s Humira in Arthritis Trial
BioSpace
Fri, 11/1/19 - 11:50 am
Novartis
Cosentyx
AbbVie
Humira
clinical trial
psoriatic arthritis
Pages
1
2
3
4
next ›
last »